Carbon-11 labeled cathepsin K inhibitors: Syntheses and preliminary in vivo evaluation
- 18 February 2014
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 41 (5) , 384-389
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Proteases involved in cartilage matrix degradation in osteoarthritisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2012
- Non-Invasive Imaging of Cysteine Cathepsin Activity in Solid Tumors Using a 64Cu-Labeled Activity-Based ProbePLOS ONE, 2011
- Technetium-labelled cathepsin B inhibitors as molecular imaging agentsNuclear Medicine and Biology, 2010
- Targeting the αvβ3 Integrin for Small-Animal PET/CT of Osteolytic Bone MetastasesJournal of Nuclear Medicine, 2009
- Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivoBone, 2009
- New chemotypes for cathepsin K inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Novel scaffold for cathepsin K inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasisMolecular Carcinogenesis, 2007
- β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: Modification of the 1,2-disubstituted aromatic coreBioorganic & Medicinal Chemistry Letters, 2007
- Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence SensorCirculation, 2007